Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia

Blood

Volumn 94, Issue 2, 1999, Pages 694-700

  Dorak, M Tevfik ^a   Lawson, Tom ^a   Machulla, Helmut K G ^a   Darke, Chris ^a   Mills, Ken I ^a   Burnett, Alan K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLELE; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CROSS REACTION; FEMALE; GENETIC RISK; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0033566330     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.2.694     Document Type: Article

References (63)

1. Miller RW, Young JLJr, Novakovic B: Childhood cancer. Cancer 75:395, 1995
2. Shu XO: Epidemiology of childhood leukemia. Curr Opin Hematol 4:227, 1997
3. Robison LL, Buckley JD, Bunin G: Assessment of environmental and genetic factors in the etiology of childhood cancers: The Childrens Cancer Group epidemiology program (review). Environ Health Perspect 103:111, 1995 (suppl 6)
4. Greaves MF: Aetiology of acute leukaemia. Lancet 349:344, 1997
5. Stewart A, Webb J, Hewitt D: A survey of childhood malignancies. BMJ 1:1495, 1958
6. van Steensel-Moll HA, Valkenburg HA, Vandenbroucke JP, van Zanen GE: Are maternal fertility problems related to childhood leukaemia? Int J Epidemiol 14:555, 1985
7. Yeazel MW, Buckley JD, Woods WG, Ruccione K, Robison LL: History of maternal fetal loss and increased risk of childhood acute leukemia at an early age. A report from the Childrens Cancer Group. Cancer 75:1718, 1995
8. Greaves MF, Alexander FE: An infectious etiology for common acute lymphoblastic leukemia in childhood? Leukemia 7:349, 1993
9. Kinlen LJ: Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer 71:1, 1995
10. Dorak MT: The implications for childhood leukemia of infection with adenovirus. Trends Microbiol 4:60, 1996
11. Lilly F, Boyse EA, Old LJ: Genetic basis of susceptibility to viral leukaemogenesis. Lancet 2:1207, 1964
12. Dorak MT, Burnett AK: Major histocompatibility complex, t-complex, and leukemia (review). Cancer Causes Control 3:273, 1992
13. Tiwari JL, Terasaki PI: HLA and Disease Associations. New York, NY, Springer-Verlag, 1985
14. Dorak MT, Owen G, Galbraith I, Henderson N, Webb D, Mills KI, Darke, C, Burnett AK: Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia. Leukemia 9:875, 1995
15. Taylor GM, Robinson MD, Binchy A, Birch JM, Stevens RF, Jones PM, Carr T, Dearden S, Gokhale DA: Preliminary evidence of an association between HLA-DPB1*0201 and childhood common acute lymphoblastic leukaemia supports an infectious aetiology. Leukemia 9:440, 1995
16. Von Fliedner VE, Merica H, Jeannet M, Barras C, Feldges A, Imbach P, Wyss M: Evidence for HLA-linked susceptibility factors in childhood leukemia. Hum Immunol 8:183, 1983
17. Thomas ML, Harger JH, Wagener DK, Rabin BS, Gill TJ III: HLA sharing and spontaneous abortion in humans. Am J Obstet Gynecol 151:1053, 1985
18. Jin K, Ho HN, Speed TP, Gill TJ III: Reproductive failure and the major histocompatibility complex. Am J Hum Genet 56:1456, 1995
19. Leen MP, Gorski J: DRB4 promoter polymorphism in DR7 individuals: Correlation with DRB4 pre-mRNA and mRNA levels. Immunogenetics 45:371, 1997
20. Knowles RW, Flomenberg N, Horibe K, Winchester R, Radka SF, Dupont B: Complexity of the supertypic HLA-DRw53 specificity: Two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype. J Immunol 137:2618, 1986
21. Seremetis S, Cuttner J, Winchester R: Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope. J Clin Invest 76:1391, 1985
22. Dyer PA, Ridway JC, Flanagan NG: HLA-A,B and DR antigens in chronic lymphocytic leukaemia. Dis Markers 4:231, 1986
23. Dorak MT, Chalmers EA, Gaffney D, Wilson DW, Galbraith I, Henderson, N, Worwood M, Mills KI, Burnett AK: Human major histocompatibility complex contains several leukemia susceptibility genes. Leuk Lymphoma 12:211, 1994
24. Dorak MT, Machulla HK, Hentschel M, Mills KI, Langner J, Burnett AK: Influence of the major histocompatibility complex on age at onset of chronic lymphoid leukaemia. Int J Cancer 65:134, 1996
25. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
26. Yoshida M, Kimura A, Numano F, Sasazuki T: Polymerase-chain-reaction-based analysis of polymorphism in the HLA-B gene. Hum Immunol 34:257, 1992
27. Dressel R, Gunther E: A pentanucleotide tandem duplication polymorphism in the 3′ untranslated region of the HLA-linked heat-shock protein 70-2 (HSP70-2) gene. Hum Genet 94:585, 1994
28. Kogan SC, Doherty M, Gitschier J: An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A. N Engl J Med 317:985, 1987
29. Daly LE, Bourke GJ, McGilvray J: Interpretation and Uses of Medical Statistics. Oxford, UK, Blackwell, 1991
30. Svejgaard A, Ryder LP: HLA and disease associations: Detecting the strongest association. Tissue Antigens 43:18, 1994
31. de Moerloose P, Chardonnens X, Vassalli P, Jeannet M: [HL-AD antigens from B-lymphocytes and susceptibility to certain diseases]. Schweiz Med Wochenschr 107:1461, 1977
32. Casper JT, Duquesnoy RJ, Borella L: Transient appearance of HLA-DRw-positive leukocytes in peripheral blood after cessation of antileukemia therapy. Transplant Proc 12:130, 1980
33. Von Fliedner VE, Sultan-Khan Z, Jeannet M: HLA-DRw antigens associated with acute leukemia. Tissue Antigens 16:399, 1980
34. Michel K, Hubbel C, Dock NL, Davey FR: Correlation of HLA-DRw3 with childhood acute lymphocytic leukemia (letter). Arch Pathol Lab Med 105:560, 1981
35. Chan KW, Pollack MS, Braun D Jr, O'Reilly RJ, Dupont B: Distribution of HLA genotypes in families of patients with acute leukemia. Implications for transplantation. Transplantation 33:613, 1982
36. de Jongh BM, van der Dose-van den Berg A, Schreuder GM: Random HLA-DR distribution in children with acute lymphocytic leukaemia in long-term continuous remission. Br J Haematol 52:161, 1982
37. Navarrete C, Alonso A, Awad J, McCloskey D, Ganesan TS, Amess J, Lister TA, Festenstein H: HLA class I and class II antigen associations in acute leukaemias. J Immunogenet 13:77, 1986
38. Bortin MM, D'Amaro J, Bach FH, Rimm AA, van Rood JJ: HLA associations with leukemia. Blood 70:227, 1987
39. Orgad S, Cohen IJ, Neumann Y, Vogel R, Kende G, Ramot B, Zaizov R, Gazit E: HLA-All is associated with poor prognosis in childhood acute lymphoblastic leukemia (ALL). Leukemia 2:79S, 1988
40. Caruso C, Cammarata G, Sireci G, Modica MA: HLA-Cw4 association with acute lymphoblastic leukaemia in Sicilian patients. Vox Sang 54:57, 1988
41. Dearden SP, Taylor GM, Gokhale DA, Robinson MD, Thompson W, Ollier W, Binchy A, Birch JM, Stevens RF, Carr T, Bardsley WG: Molecular analysis of HLA-DQB1 alleles in childhood common acute lymphoblastic leukaemia. Br J Cancer 73:603, 1996
42. Boyse EA, Old LJ, Stockert E: The relation of linkage group IX to leukemogenesis in the mouse, in Emmelot P, Bentvelzen P (eds): RNA Viruses and Host Genome in Oncogenesis. Amsterdam, The Netherlands, North Holland, 1972, p 171
43. Lilly F, Pincus T: Genetic control of murine viral leukemogenesis. Adv Cancer Res 17:231, 1973
44. Vasmel WL, Zijlstra M, Radaszkiewicz T, Leupers CJ, de Goede RE, Melief CJ: Major histocompatibility complex class II-regulated immunity to murine leukemia virus protects against early T- but not late B-cell lymphomas. J Virol 62:3156, 1988
45. Miyazawa M, Nishio J, Chesebro B: Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genes. J Exp Med 168:1587, 1988
46. Matsuyama T, Schwenzer J, Silver J, Winchester R: Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity. J Immunol 137:934, 1986
47. Weyand CM, Hicok KC, Conn DL, Goronzy JJ: The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117:801, 1992
48. MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A: HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: Increased association in men, young age at onset, and disease severity. J Rheumatol 22:1032, 1995
49. Dorak MT, Mills KI, Gaffney D, Wilson DW, Galbraith I, Henderson N, Burnett AK: Homozygous MHC genotypes and longevity. Hum Hered 44:271, 1994
50. Ober C, Elias S, Kostyu DD, Hauck WW: Decreased fecundability in Hutterite couples sharing HLA-DR. Am J Hum Genet 50:6, 1992
51. Ober C, Hyslop T, Elias S, Weitkamp LR, Hauck WW: Human leukocyte antigen matching and fetal loss: Results of a 10 year prospective study. Hum Reprod 13:33, 1998
52. Bechtol KB: Lethality of heterozygotes between t-haplotype complementation groups of mouse: Sex-related effect on lethality of t6/tw5 heterozygotes. Genet Res 39:79, 1982
53. King TR: Partial complementation by murine t haplotypes: Deficit of males among t6/tw5 double heterozygotes and correlation with transmission-ratio distortion. Genet Res 57:55, 1991
54. Silver LM: Genomic analysis of the H-2 complex region associated with mouse t haplotypes. Cell 29:961, 1982
55. Sebastiani GD, Galeazzi M, Morozzi G, Marcolongo R: The immunogenetics of the antiphospholipid syndrome, anticardiolipin antibodies, and lupus anticoagulant (review). Semin Arthritis Rheum 25:414, 1996
56. Rai R, Clifford K, Regan L: The modern preventative treatment of recurrent miscarriage. Br J Obstet Gynaecol 103:106, 1996
57. Gill TJ III: The borderland of embryogenesis and carcinogenesis. Major histocompatibility complex-linked genes affecting development and their possible relationship to the development of cancer. Biochim Biophys Acta 738:93, 1984
58. Gill TJ III: Role of the major histocompatibility complex region in reproduction, cancer, and autoimmunity. Am J Reprod Immunol 35:211, 1996
59. Kendall E, Todd JA, Campbell RD: Molecular analysis of the MHC class II region in DR4, DR7, and DR9 haplotypes. Immunogenetics 34:349, 1991
60. Niven MJ, Hitman GA, Pearce H, Marshall B, Sachs JA: Large haplotype-specific differences in inter-genic distances in human MHC shown by pulsed field electrophoresis mapping of healthy and type 1 diabetic subjects. Tissue Antigens 36:19, 1990
61. Inoko H, Ando A, Kawai J, Trowsdale J, Tsuji K: Mapping of the HLA-D region by pulsed-field gel electrophoresis: Size variation in subregion intervals, in Silver J (ed): Molecular Biology of HLA Class II Antigens. Boca Raton, FL, CRC, 1990, p 1
62. Dorak MT, Burnett AK: Molecular mimicry of an HLA-DR53 epitope by viruses (letter). Immunol Today 15:138, 1994
63. Schlehofer B, Blettner M, Geletneky K, Haaf HG, Kaatsch P, Michaelis J, Mueller-Lantzsch N, Niehoff D, Winkelspecht B, Wahrendorf J, Schlehofer JR: Sero-epidemiological analysis of the risk of virus infections for childhood leukaemia. Int J Cancer 65:584, 1996